• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Kids v Cancer

A PEDIATRIC CANCER THINK TANK

DONATE
  • GIVE KIDS A CHANCE act
  • RACE for Children Act
  • Creating Hope Act Pediatric Vouchers
  • CLIMB THE HILL
    • What is Climb the Hill Day?
    • Climb the Hill Youth Advocacy Day Sign Up
    • Video and photo gallery
    • (video) Climb the Hill Youth Advocacy Day — Why Do We Do It?
  • Compassionate Use Navigator
    • Information for Families
    • Information for Physicians
  • Who We Are
    • About Us
    • Mission and Impact
    • Contact
  • News & publications
    • Kids v Cancer in the News
    • Kids v Cancer Publications

(Blog) FDA’s guidance calls for early consideration of pediatric drug development

June 17, 2019

Certain populations — including children — are often excluded from trials without strong clinical or scientific justification. This guidance recommends approaches that sponsors of clinical trials can take to broaden eligibility criteria, when scientifically and clinically appropriate, and increase enrollment of underrepresented populations in their clinical trials.

Among other recommendations, FDA suggests to consider including children (ages 2 to 11 years) and adolescents ( ages 12 to 17 years) in confirmatory clinical trials involving adults when appropriate.

It also suggest considering pediatric development program early, and  staggering enrollment based on age (i.e., enrollment of older pediatric participants first, then younger pediatric participants) for pediatric trials with potential safety concerns.

Read the full text:  “Enhancing the Diversity of Clinical Trial Populations — Eligibility Criteria, Enrollment Practices, and Trial Designs”.

  • We are in the news
  • Our Publications
  • Our Op-Eds & Speeches
  • Legislation / Proclamations
  • Videos / Photos
  • RELEVANT NEWS
    • RACE for Children Act
    • Creating Hope Act/ Pediatric vouchers
    • Compassionate Use
    • Kids’ Eligibility for Trials
  • Facebook
  • Twitter

DONATE SUBSCRIBE

Kids v Cancer · 3602 Newark Street NW · Washington D.C. 20016 · 646-361-3590 · contact

© 2023 Kids v Cancer · All Rights Reserved a 501(c)(3) nonprofit organization · EIN 27-1427784 · Privacy Policy · Terms of Use · Sitemap